HALOZYME THERAPEUTICS INC's ticker is and the CUSIP is 40637HAD1.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,013,000 | +16.2% | 1,200,000 | +14.3% | 0.00% | – |
| Q2 2023 | $872,000 | +7166.7% | 1,050,000 | +7400.0% | 0.00% | – |
| Q1 2023 | $12,000 | -99.7% | 14,000 | -99.7% | 0.00% | -100.0% |
| Q2 2022 | $4,441,000 | -31.2% | 5,034,000 | -32.1% | 0.00% | -50.0% |
| Q1 2022 | $6,459,000 | – | 7,414,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Wellesley Asset Management | 70,776,482 | $60,420,911 | 4.46% |
| Lombard Odier Asset Management (Europe) Ltd | 41,798,000 | $35,110,320 | 1.74% |
| CAMDEN ASSET MANAGEMENT L P /CA | 47,123,000 | $39,937,073 | 1.34% |
| Penn Mutual Asset Management | 1,555,000 | $1,318,197 | 1.25% |
| DAVIDSON KEMPNER PARTNERS | 66,537,000 | $56,390,573 | 1.09% |
| DAVIDSON KEMPNER CAPITAL MANAGEMENT LP | 66,537,000 | $56,390,573 | 0.96% |
| ZAZOVE ASSOCIATES LLC | 9,443,000 | $8,011 | 0.73% |
| SHENKMAN CAPITAL MANAGEMENT INC | 8,934,000 | $7,582,430 | 0.58% |
| CSS LLC/IL | 8,000,000 | $6,788,288 | 0.45% |
| READYSTATE ASSET MANAGEMENT LP | 5,000,000 | $4,262,534 | 0.40% |